ROCKVILLE, Md., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, announced today that Peter D. Suzdak, Ph.D., the Company’s Chief Executive Officer, will be presenting at the 9 th Annual Biotech Showcase™ 2017 conference. Dr. Suzdak is scheduled to present at 8:30 a.m. PST on Tuesday, January 10, 2017, in Room 7 (Ballroom Level) at the Hilton San...